Alnylam Pharmaceuticals Reports First Quarter 2022 Financial Results and Highlights Recent Period Activity

Go back to Alnylam Pharmaceuticals Reports First Quarter 2022 Financial Results and Highlights Recent Period Activity

Alnylam Pharma (ALNY) Tops Q1 EPS by 35c

April 28, 2022 8:08 AM EDT

Alnylam Pharma (NASDAQ: ALNY) reported Q1 EPS of ($1.49), $0.35 better than the analyst estimate of ($1.84). Revenue for the quarter came in at $213.26 million versus the consensus estimate of $243.02 million.

For earnings history and earnings-related data on Alnylam Pharma (ALNY) click here.

... More